logo

Nabriva Therapeutics (NBRV)



Trade NBRV now with
  Date
  Headline
12/11/2020 12:00:30 AM Nabriva Therapeutics Prices Public Offering Of 6 Mln Ordinary Shares At $2.50/Shr
7/16/2020 4:18:33 PM Nabriva: XENLETA Gets Health Canada Approval For Treatment Of Community Acquired Pneumonia
12/20/2019 8:38:03 AM Nabriva Therapeutics Announces $20 Mln Registered Direct Offering
12/20/2019 6:08:11 AM Nabriva Therapeutics Resubmits New Drug Application For Intravenous CONTEPO For Injection
9/9/2019 7:04:38 AM Nabriva Therapeutics: Oral And IV Formulations Of XENLETA Now Available In US
8/9/2019 9:47:14 AM Wedbush Is Cutting Nabriva Therapeutics (NBRV) FY20 Estimate To -1.02 From -0.30
8/9/2019 9:47:01 AM Wedbush Is Lowering Nabriva Therapeutics (NBRV) Q4 20 Estimate To -0.19 From -0.01
8/9/2019 9:46:49 AM Wedbush Is Lowering Nabriva Therapeutics (NBRV) Q3 20 Estimate To -0.39 From -0.06
8/9/2019 9:46:37 AM Wedbush Is Lowering Nabriva Therapeutics (NBRV) Q2 20 Estimate To -0.20 From -0.10
8/9/2019 9:46:25 AM Wedbush Is Lowering Nabriva Therapeutics (NBRV) Q1 20 Estimate To -0.24 From -0.13